Breaking News Instant updates and real-time market news.

ATHN

athenahealth

$130.07

23.79 (22.38%)

07:02
05/19/17
05/19
07:02
05/19/17
07:02

athenahealth price target raised to $154 from $119 at Oppenheimer

Oppenheimer analyst Mohan Naidu raised his price target for athenahealth to $154 after hosting investor meetings with management. The analyst hopes the presence of Elliott Management "doesn't drastically change the focus on creating the disruptive next-generation healthcare platform for near-term gain." He notes that management expressed confidence in their new guidance. Naidu keeps an Outperform rating on athenahealth.

  • 22

    May

  • 07

    Jun

ATHN athenahealth
$130.07

23.79 (22.38%)

05/19/17
JEFF
05/19/17
UPGRADE
Target $135
JEFF
Hold
athenahealth upgraded to Hold from Underperform at Jefferies
Jefferies analyst Sean Dodge upgraded athenahealth to Hold saying the involvement of activist Elliott Associates limits near-term downside and increases the chances of a sale. The analyst remains concerned about the company's fundamentals, however. A sale is a low probability event but can't be ruled out, Dodge tells investors in a research note. He upped his price target for athenahealth to $135 from $95.
05/18/17
PIPR
05/18/17
NO CHANGE
PIPR
Overweight
Piper says selling athenahealth at this point a bad 'get rich quick' strategy
After activist investor Elliot Associates disclosed a 9.3% stake in athenahealth, Piper Jaffray analyst Sean Wieland said he agrees "wholeheartedly" that the shares are undervalued, but he contends that selling the company at this point does not line up well with the goals of stakeholders and would be no more than a "get rich quick" strategy. The analyst, in a note entitled "Nobody Puts Johnny in a Corner," said the company's takeover defenses are strong and he believes the greatest opportunity is to let founder and CEO Jonathan Bush work on disrupting the status quo in healthcare. However, if Elliott could help implement more operational discipline, "everyone wins," said Wieland, who keeps an Overweight rating on the shares.
05/18/17
BARD
05/18/17
NO CHANGE
Target $140
BARD
Outperform
athenahealth price target raised to $140 at Baird after Elliott discloses stake
After Elliot Associates disclosed a 9.3% stake in athenahealth, Baird analyst Matthew Gillmor said he is optimistic the activist investor will have a positive influence though he thinks a takeout is less likely. He thinks margin improvement "may be the path of least resistance" and that Elliot's stake highlights athenahealth's unique competitive positioning "at the very least." Gillmor keeps an Outperform rating on athenahealth shares and raised his price target to $140 from $130.
05/18/17
EVER
05/18/17
NO CHANGE
Target $147
EVER
Outperform
athenahealth price target raised to $147 from $119 at Evercore ISI

TODAY'S FREE FLY STORIES

GLW

Corning

$30.01

-0.05 (-0.17%)

07:18
10/24/17
10/24
07:18
10/24/17
07:18
Earnings
Corning reports Q3 core EPS 43c, consensus 41c »

Reports Q3 GAAP revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

HYGS

Hydrogenics

07:16
10/24/17
10/24
07:16
10/24/17
07:16
Conference/Events
TMX Group to hold a conference »

TSX Industrial &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 06

    Nov

  • 16

    Nov

THR

Thermon Group

$21.40

0.4 (1.90%)

07:16
10/24/17
10/24
07:16
10/24/17
07:16
Recommendations
Thermon Group analyst commentary  »

Thermon Group price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PEGA

Pegasystems

$59.15

-0.3 (-0.50%)

07:16
10/24/17
10/24
07:16
10/24/17
07:16
Recommendations
Pegasystems analyst commentary  »

Pegasystems should be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SHW

Sherwin-Williams

$386.58

-3.12 (-0.80%)

07:16
10/24/17
10/24
07:16
10/24/17
07:16
Technical Analysis
Technical View: Sherwin-Williams slips lower after results »

The stock was last down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 30

    Oct

ELVT

Elevate Credit

$7.52

-0.14 (-1.83%)

, FPAY

FlexShopper

07:15
10/24/17
10/24
07:15
10/24/17
07:15
Conference/Events
Stephens to hold meetings at conference »

Stephens Hosted Company…

ELVT

Elevate Credit

$7.52

-0.14 (-1.83%)

FPAY

FlexShopper

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 30

    Oct

CTMX

CytomX Therapeutics

$20.04

-0.12 (-0.60%)

07:15
10/24/17
10/24
07:15
10/24/17
07:15
Initiation
CytomX Therapeutics initiated  »

CytomX Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$171.27

-3.71 (-2.12%)

07:15
10/24/17
10/24
07:15
10/24/17
07:15
Periodicals
Facebook faces EU-wide privacy fights after top court setback, Bloomberg says »

Facebook may faces…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 01

    Nov

  • 08

    Nov

  • 15

    Nov

HFC

HollyFrontier

07:15
10/24/17
10/24
07:15
10/24/17
07:15
Downgrade
HollyFrontier rating change  »

HollyFrontier downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

PBF

PBF Energy

07:15
10/24/17
10/24
07:15
10/24/17
07:15
Downgrade
PBF Energy rating change  »

PBF Energy downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LPX

Louisiana-Pacific

07:15
10/24/17
10/24
07:15
10/24/17
07:15
Initiation
Louisiana-Pacific initiated  »

Louisiana-Pacific…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

VLO

Valero

07:14
10/24/17
10/24
07:14
10/24/17
07:14
Downgrade
Valero rating change  »

Valero downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

DK

Delek US

07:14
10/24/17
10/24
07:14
10/24/17
07:14
Upgrade
Delek US rating change  »

Delek US upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Nov

ALDW

Alon USA Partners

$11.74

0.05 (0.43%)

07:14
10/24/17
10/24
07:14
10/24/17
07:14
Upgrade
Alon USA Partners rating change  »

Alon USA Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Nov

07:13
10/24/17
10/24
07:13
10/24/17
07:13
Conference/Events
Drug Information Association to hold a conference »

Biosimilars Conference is…

PEBO

Peoples Bancorp

$33.03

-0.79 (-2.34%)

07:13
10/24/17
10/24
07:13
10/24/17
07:13
Earnings
Peoples Bancorp reports Q3 EPS 60c, consensus 50c »

Reports Q3 adjusted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

WY

Weyerhaeuser

$34.82

-0.46 (-1.30%)

07:13
10/24/17
10/24
07:13
10/24/17
07:13
Initiation
Weyerhaeuser initiated  »

Weyerhaeuser initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

ALXN

Alexion

$135.21

-3.81 (-2.74%)

07:13
10/24/17
10/24
07:13
10/24/17
07:13
Recommendations
Alexion analyst commentary  »

Alexion could be up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 26

    Oct

  • 06

    Nov

PNR

Pentair

$70.82

-0.35 (-0.49%)

07:13
10/24/17
10/24
07:13
10/24/17
07:13
Hot Stocks
Breaking Hot Stocks news story on Pentair »

Pentair: Separation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PNR

Pentair

$70.82

-0.35 (-0.49%)

07:12
10/24/17
10/24
07:12
10/24/17
07:12
Earnings
Pentair sees FY17 adjusted EPS $3.53, consensus $3.51 »

Sees FY17 sales $4.9B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PNR

Pentair

$70.82

-0.35 (-0.49%)

07:12
10/24/17
10/24
07:12
10/24/17
07:12
Earnings
Pentair sees Q4 adjusted EPS approx. 93c, consensus 93c »

Sees Q4 revenue approx.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UFS

Domtar

$44.14

-0.23 (-0.52%)

07:12
10/24/17
10/24
07:12
10/24/17
07:12
Initiation
Domtar initiated  »

Domtar initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

ADDYY

adidas

$109.85

-0.45 (-0.41%)

07:11
10/24/17
10/24
07:11
10/24/17
07:11
Initiation
adidas initiated  »

adidas initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABG

Asbury Automotive

$56.05

0.2 (0.36%)

07:11
10/24/17
10/24
07:11
10/24/17
07:11
Earnings
Asbury Automotive reports Q3 EPS $1.48 with items, consensus $1.51 »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

PNR

Pentair

$70.82

-0.35 (-0.49%)

07:11
10/24/17
10/24
07:11
10/24/17
07:11
Earnings
Pentair reports Q3 adjusted EPS 95c, consensus 93c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.